Anmeldung
Gruppen
Forscher/innen
Ergebnisse
HOSPITAL UNIVERSITARIO RUBER
Fachbereich
First Hospital of Jilin University
Changchun, China
Sie sind in
Zusammenarbeiten
First Hospital of Jilin University
Publikationen in Zusammenarbeit mit Forschern von First Hospital of Jilin University (2)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
2016
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366
Kontakt
Rechtlicher Hinweis
Hilfe
translate
de
arrow_drop_down
translate
de
arrow_drop_down
es
ca
eu
gl
en
fr